These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors. Johnson SL; Chen LH; Barile E; Emdadi A; Sabet M; Yuan H; Wei J; Guiney D; Pellecchia M Bioorg Med Chem; 2009 May; 17(9):3352-68. PubMed ID: 19359184 [TBL] [Abstract][Full Text] [Related]
25. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design. Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885 [TBL] [Abstract][Full Text] [Related]
26. War against anthrax. Khanna H; Singh Y Mol Med; 2001 Dec; 7(12):795-6. PubMed ID: 11844866 [No Abstract] [Full Text] [Related]
27. Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies. Johnson SL; Jung D; Forino M; Chen Y; Satterthwait A; Rozanov DV; Strongin AY; Pellecchia M J Med Chem; 2006 Jan; 49(1):27-30. PubMed ID: 16392787 [TBL] [Abstract][Full Text] [Related]
28. Improving the anti-toxin abilities of the CMG2-Fc fusion protein with the aid of computational design. Xi Y; Wu X; Gao L; Shao Y; Peng H; Chen H; Chen H; Hu X; Yue J PLoS One; 2014; 9(8):e104674. PubMed ID: 25101992 [TBL] [Abstract][Full Text] [Related]
29. Identification of the cellular receptor for anthrax toxin. Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562 [TBL] [Abstract][Full Text] [Related]
30. Anthrax Pathogenesis. Moayeri M; Leppla SH; Vrentas C; Pomerantsev AP; Liu S Annu Rev Microbiol; 2015; 69():185-208. PubMed ID: 26195305 [TBL] [Abstract][Full Text] [Related]
32. How anthrax kills. Hanna P Science; 1998 Jun; 280(5370):1671, 1673-4. PubMed ID: 9660700 [No Abstract] [Full Text] [Related]
33. Inhibitors of Bacillus anthracis edema factor. Seifert R; Dove S Pharmacol Ther; 2013 Nov; 140(2):200-12. PubMed ID: 23850654 [TBL] [Abstract][Full Text] [Related]
34. Screening inhibitors of anthrax lethal factor. Tonello F; Seveso M; Marin O; Mock M; Montecucco C Nature; 2002 Jul; 418(6896):386. PubMed ID: 12140548 [TBL] [Abstract][Full Text] [Related]
35. Anthrax lethal factor inhibitors as potential countermeasure of the infection. Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802 [TBL] [Abstract][Full Text] [Related]
36. The roles of anthrax toxin in pathogenesis. Moayeri M; Leppla SH Curr Opin Microbiol; 2004 Feb; 7(1):19-24. PubMed ID: 15036135 [TBL] [Abstract][Full Text] [Related]
37. Certhrax toxin, an anthrax-related ADP-ribosyltransferase from Bacillus cereus. Visschedyk D; Rochon A; Tempel W; Dimov S; Park HW; Merrill AR J Biol Chem; 2012 Nov; 287(49):41089-102. PubMed ID: 22992735 [TBL] [Abstract][Full Text] [Related]
38. Receptors of anthrax toxin and cell entry. van der Goot G; Young JA Mol Aspects Med; 2009 Dec; 30(6):406-12. PubMed ID: 19732789 [TBL] [Abstract][Full Text] [Related]